13F-HR filed by New Leaf Venture Partners, L.L.C.
New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-10, with 14 holding rows worth $116,438,264.
- Accession
- 0000950123-23-007238
- Filer
- CIK 1631614
- Filed
- 2023-08-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 14 entries on the cover page, a total value of $116,438,264 stated on the cover page (in dollars after the unit check, H1), rows summing to $116,438,264 with VALUE read as dollars as filed, 13F file number 028-16681. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARVINAS INC | 04335A105 | COM | 1,289,521 | $32,005,911 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 3,301,603 | $18,687,073 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 371,693 | $17,268,857 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,209,571 | $17,030,760 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,553,661 | $12,040,873 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 501,530 | $5,938,115 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 141,000 | $2,540,820 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 118,242 | $2,349,469 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 2,497,922 | $2,348,047 | dollars as filed | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 3,156,699 | $2,241,256 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 339,569 | $2,040,810 | dollars as filed | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 946,423 | $1,192,493 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 335,000 | $649,900 | dollars as filed | |
| ITERUM THERAPEUTICS PLC | G6333L200 | COM | 97,084 | $103,880 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-007238 | this filing | 2023-08-10 | acceptance time not in the bulk data set |